ovixan 1 mg/g emulsiovoide
galenica ab - mometasone furoate - emulsiovoide - 1 mg/g - mometasoni
fluticason orion 125 mikrog/annos inhalaatiosumute, suspensio
orion corporation - fluticasoni propionas - inhalaatiosumute, suspensio - 125 mikrog/annos - flutikasoni
fluticason orion 250 mikrog/annos inhalaatiosumute, suspensio
orion corporation - fluticasoni propionas - inhalaatiosumute, suspensio - 250 mikrog/annos - flutikasoni
elosalic voide
schering-plough europe - happo salicylicum,mometasoni furoas - voide - mometasoni
tybost
gilead sciences ireland uc - cobicistat - hiv-infektiot - antiviraalit systeemiseen käyttöön - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.
darunavir sandoz 75 mg tabletti, kalvopäällysteinen
sandoz a/s sandoz a/s - darunavirum - tabletti, kalvopäällysteinen - 75 mg - darunaviiri
mommox 50 mikrog/annos nenäsumute, suspensio
sandoz a/s - mometasone furoate monohydrate - nenäsumute, suspensio - 50 mikrog/annos - mometasoni
nenoxin 50 mikrog/annos nenäsumute, suspensio
oy verman ab - mometasone furoate monohydrate - nenäsumute, suspensio - 50 mikrog/annos - mometasoni
momesonex 50 mikrog/annos nenäsumute, suspensio
teva pharma b.v. - mometasone furoate monohydrate - nenäsumute, suspensio - 50 mikrog/annos - mometasoni
mometason orion 50 mikrog/annos nenäsumute, suspensio
orion corporation - mometasone furoate monohydrate - nenäsumute, suspensio - 50 mikrog/annos - mometasoni